FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 10, 2004
Table of Contents
Docket # Title
1986V-0090 SPECTRASCAN PROJECTOR WITH HS-100 SCANNING CONTROL SYSTEM
1988N-0004 Pediatric dosing information for OTC; request for informatio
1993V-0133 Laser Light Show
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1999P-1340 Declared Eternity eau de Parfum Misbranded
1999P-2630 Establish a Daily Value for "added sugars"
1999P-5106 Identify Sources of Natural Flavorings
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
2003D-0554 Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
2003D-0562 Compliance Policy Guide Sec.110.300 Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0169 Dental Amalgam; Request for Information
2003N-0481 Agency Information Collection Activities; Proposed Collection; Comment Request; Food Additive Petitions
2003V-0293 Laser Light Show
2003V-0306 Laser Light Show
2004D-0465 Guidance for FDA Review Staff and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)
2004D-0466 Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act
2004D-0468 Draft Guidance for Industry on Development of Target Animal Safety and Effectiveness Data to Support Approval of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) for use in Animals
2004N-0244 Agency Information Collection Activities: Proposed Collection; Comment Request;
2004N-0332 Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
2004N-0428 Preparation for the International Conference on Harmonization Meetings in Yokohama, Japan: Public Meeting
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
2004N-0470 Agency Information Collection Activities: Proposed Collection; Comment Request;
2004N-0480 The Minor Use & Minor Species (MUMS) Animal Health Act
2004N-0502 Animal Models and Correlates of Protection for Plague Vaccines, Public Workshop
2004P-0059 Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
2004P-0489 ANADA Suitability Petition for generic serum gonadotropin and chorionic gonadotropin for injection
2004P-0500 Meperidine Hydrochloirde Tablets in two strengths of 75 mg and 150 mg suitable for ANDA
2004Q-0144 Qualified Health Claim (QHC): Chromium picolinate and Diabetes
1986V-0090 SPECTRASCAN PROJECTOR WITH HS-100 SCANNING CONTROL SYSTEM
VRA 7 HFZ-300 to Holo Spectra, Inc. Vol #: 1
1988N-0004 Pediatric dosing information for OTC; request for informatio
BKG 1 Background Material Vol #: 1
1993V-0133 Laser Light Show
VRA 6 HFZ-300 to Flandrau Science Center & Planetarium Vol #: 1
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 14729 Perrigo Company of South Carolina Vol #: 129
LET 14730 Perrigo Company of South Carolina Vol #: 129
LET 14731 Perrigo Company of South Carolina Vol #: 129
LET 14732 Ashbury Biologicals Inc. Vol #: 129
LET 14733 Ashbury Biologicals Inc. Vol #: 129
LET 14734 Ajinomoto U.S.A., Inc. Vol #: 129
LET 14735 Advocare International, L.P. Vol #: 129
LET 14736 Fitness Labs Nutrition Corporation Vol #: 129
LET 14737 Fitness Labs Nutrition Corporation Vol #: 129
LET 14738 Fitness Labs Nutritiion Corporation Vol #: 129
LET 14739 Fitness Labs Nutrition Corporation Vol #: 129
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
EMC 4288 P. Pannucci Vol #: 320
EMC 4289 P. Pannucci Vol #: 320
EMC 4290 A. Mithoff Vol #: 320
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 559 D. Steinberg Vol #: 24
1999P-2630 Establish a Daily Value for "added sugars"
C 617 S. Brown Vol #: 33
1999P-5106 Identify Sources of Natural Flavorings
SUP 1 R. Claypool Vol #: 3
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 10987 N. Lai Vol #: 296
EMC 10988 B. Dore Vol #: 286
EMC 10989 E. Chang Vol #: 296
EMC 10990 S. Adams Vol #: 296
EMC 10991 F. Frenkel Vol #: 296
EMC 10992 A. Denholtz Vol #: 296
EMC 10993 C. Gunn Vol #: 296
EMC 10994 S. Kessler Vol #: 296
EMC 10995 J. Seifert Vol #: 296
EMC 10996 L. Farrar Vol #: 296
EMC 10997 S. Schmidt Vol #: 296
EMC 10998 J. Dumin Vol #: 296
EMC 10999 T. Eckert Vol #: 296
EMC 11000 D. Bass Vol #: 296
EMC 11001 A. Gatewood Vol #: 296
EMC 11002 R. Osborn Vol #: 296
EMC 11003 M. Frier Vol #: 296
EMC 11004 M. Wilkerson Vol #: 296
EMC 11005 N. Satchidanand Vol #: 296
EMC 11006 K. Campbell Vol #: 296
EMC 11007 C. Romeo Vol #: 296
EMC 11008 S. Waxler Vol #: 296
EMC 11009 C. Kerr Vol #: 296
EMC 11010 L. Battis Vol #: 296
EMC 11011 T. Bigford Vol #: 296
EMC 11012 T. Bigford Vol #: 296
EMC 11013 K. Bonning Vol #: 296
EMC 11014 T. Hanigan Vol #: 296
EMC 11015 K. Lewis Vol #: 296
EMC 11016 M. Tafoya Vol #: 296
EMC 11017 C. Molitor Vol #: 296
EMC 11018 M. Stratton Vol #: 296
EMC 11019 J. Layton Vol #: 296
EMC 11020 D. Wahl Vol #: 296
EMC 11021 L. Eisenpresser Vol #: 296
EMC 11022 M. Renteria Vol #: 296
EMC 11023 C. Winslow Vol #: 296
EMC 11024 T. Bradshaw Vol #: 296
EMC 11025 N. Rann Vol #: 296
EMC 11026 B. Bowen Vol #: 296
EMC 11027 J. Nichols Vol #: 296
EMC 11028 L. Wilson Vol #: 296
EMC 11029 A. Beyerlein Vol #: 296
EMC 11030 E. Stinaff Vol #: 296
EMC 11031 N. Alesio Vol #: 296
EMC 11032 R. Klos Vol #: 296
EMC 11033 D. O'Connor Vol #: 296
EMC 11034 E. Edenfield Vol #: 296
EMC 11035 H. Malave Vol #: 296
EMC 11036 M. Hammond Vol #: 296
EMC 11037 K. Hobson Vol #: 296
EMC 11038 J. Kennedy Vol #: 296
EMC 11039 R. Ponsaran Vol #: 296
EMC 11040 M. Karels Vol #: 296
EMC 11041 D. Jenkins Vol #: 296
EMC 11042 L. Wilson Vol #: 296
EMC 11043 G. Stewart, RN Vol #: 296
EMC 11044 C. Jack Vol #: 296
EMC 11045 P. Dickerson Vol #: 296
EMC 11046 K. Delaney Vol #: 296
EMC 11047 R. Gearhart Vol #: 296
EMC 11048 J. Holman Vol #: 296
EMC 11049 M. Charles Vol #: 296
EMC 11050 N. Mark Vol #: 296
EMC 11051 M. Leith Vol #: 296
EMC 11052 V. Rettmann Vol #: 296
EMC 11053 C. Gorman Vol #: 296
EMC 11054 C. Kupfer Vol #: 296
EMC 11055 J. New Vol #: 296
EMC 11056 A. Williams Vol #: 296
EMC 11057 A. Peeler Vol #: 296
EMC 11058 E. Daigneault Vol #: 296
EMC 11059 K. Haltinner Vol #: 296
EMC 11060 D. Mupotsa Vol #: 296
EMC 11061 E. Edenfield Vol #: 298
EMC 11062 C. Forrester Vol #: 296
EMC 11063 M. Burton Vol #: 296
EMC 11064 N. Clark Vol #: 296
EMC 11065 E. Bibee Vol #: 296
EMC 11066 S. Draper Vol #: 296
EMC 11067 L. Brown Vol #: 296
EMC 11068 A. Alexy Vol #: 296
EMC 11069 B. Clapper Vol #: 296
EMC 11070 S. Trieu Vol #: 296
EMC 11071 B. Peterson Vol #: 296
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
EMC 1250 D. Jong Vol #: 5
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
EMC 195 B. Hickey Vol #: 3
EMC 196 B. Hickey Vol #: 3
2003D-0554 Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
GDL 4 Guidance Vol #: 1
NAD 4 FDA Vol #: 1
2003D-0562 Compliance Policy Guide Sec.110.300 Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
GDL 2 Guidance Vol #: 1
NAD 2 FDA Vol #: 1
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 450 No signature Vol #: 9
EMC 451 J. Stevens Vol #: 9
EMC 452 C. Zvolanek Vol #: 9
EMC 453 J. Cline Vol #: 9
EMC 454 B. Pinkham, Jr. Vol #: 9
EMC 455 M. Twyford Vol #: 9
EMC 456 R. Bradsher Vol #: 9
2003N-0169 Dental Amalgam; Request for Information
EMC 276 Consumers for Dental Choice Vol #: 6
EMC 277 Consumers for Dental Choice Vol #: 6
2003N-0481 Agency Information Collection Activities; Proposed Collection; Comment Request; Food Additive Petitions
NAL 1 FDA Vol #: 1
SS 1 Supporting Statement Vol #: 1
2003V-0293 Laser Light Show
VRA 2 HFZ-300 to LumaLaser Vol #: 1
2003V-0306 Laser Light Show
VRA 1 HFZ-300 to Visiotopic System LLC Vol #: 1
2004D-0465 Guidance for FDA Review Staff and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2004D-0466 Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r) (6) of the Federal Food, Drug, and Cosmetic Act
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2004D-0468 Draft Guidance for Industry on Development of Target Animal Safety and Effectiveness Data to Support Approval of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) for use in Animals
GDL 1 Guideline Vol #: 1
NAD 1 FDA Vol #: 1
2004N-0244 Agency Information Collection Activities: Proposed Collection; Comment Request;
N 2 FDA Vol #: 1
2004N-0332 Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
N 2 FDA Vol #: 1
2004N-0428 Preparation for the International Conference on Harmonization Meetings in Yokohama, Japan: Public Meeting
NM 1 FDA Vol #: 1
TR 1 Transcript of October 19, 2004 Public Meeting Vol #: 1
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
EMC 3 T. Singeltary Sr. Vol #: 1
EMC 4 T. Singeltary Sr. Vol #: 1
2004N-0458 Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
BKG 1 Implementation Strategy Vol #: 1
NAD 1 FDA Vol #: 1
2004N-0470 Agency Information Collection Activities: Proposed Collection; Comment Request;
N 1 FDA Vol #: 1
2004N-0480 The Minor Use & Minor Species (MUMS) Animal Health Act
N 1 FDA Vol #: 1
2004N-0502 Animal Models and Correlates of Protection for Plague Vaccines, Public Workshop
NM 1 FDA Vol #: 1
TR 1
Part 2, part 3
Transcript of October 13, 2004 Workshop Vol #: 1
TR 2
Part 2
Transcript of October 14, 2004 Workshop Vol #: 2
2004P-0059 Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
EMC 2 Weider Nutrition International, Inc. Vol #: 13
2004P-0489 ANADA Suitability Petition for generic serum gonadotropin and chorionic gonadotropin for injection
WDL 1 Bioniche Animal Health USA, Inc. Vol #: 1
2004P-0500 Meperidine Hydrochloirde Tablets in two strengths of 75 mg and 150 mg suitable for ANDA
ACK 1 Lachman Consultant Services, Inc. Vol #: 1
CP 1
Attachment A, B, C
Lachman Consultant Services, Inc. Vol #: 1
2004Q-0144 Qualified Health Claim (QHC): Chromium picolinate and Diabetes
EMC 2 Emord & Associates, P.C. Vol #: 11

Page created on November 12, 2004 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management